Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis

European Journal of Haematology

Volumn 86, Issue 2, 2011, Pages 167-172

  Vayá, Amparo ^a   Plumé, Gema ^a   Bonet, Elena ^a   Carrasco, Paula ^b   Morales Suárez Varela, Maria M ^c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

C677T MTHFR mutation; Eastern Spain; Hyperhomocysteinemia; Splanchnic vein thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MESENTERIC VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SPAIN; SPLANCHNIC BLOOD FLOW; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; VEIN THROMBOSIS;

ADULT; CHOLESTEROL; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; SPAIN; SPLANCHNIC CIRCULATION; VENOUS THROMBOSIS;

EID: 78651427512     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01551.x     Document Type: Article

References (26)

1. Naess IA, Christiansen SC, Romundstad PR, Cannegierter SC, Blom HJ, Rosendaal FR, Hammerstrøm J. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population-results from the HUNT 2 study. Br J Haematol 2008;141:529-35.
2. Tsai AW, Cushman M, Tsai MY, Heckbert SR, Rosamond WD, Aleksic N, Yanez ND, Psaty BM, Folsom AR. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Hematol 2003;72:192-200.
3. Amitrano L, Guardascione MA, Ames PR, Margaglione M, Antinolfi I, Iannaccone L, Annunziata M, Ferrara F, Brancaccio V, Balzano A. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol 2003;72:75-81.
4. Primignani M, Mannucci PM. The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 2008;28:293-301.
5. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med 2007;167:497-501.
6. Schneede J, Refsum H, Ueland PM. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000;26:263-79.
7. Botto LD, Yang Q. 5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: a HuGE Review. Am J Epidemiol 2000;151:862-77.
8. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, Dandrea G, Ames PR, Marmo R, Mosca S, Balzano A. High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol 2001;96:146-9.
9. Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-91.
10. Madonna P, De Stefano V, Coppola A, Cerbone AM, Di Minno G. G20210A prothrombin gene mutation and other thrombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology 2001;120:1059-60.
11. Salama K, El-Koofy N, El-Hawary M, El-Raziky M, Abou-El ElaM, Ali H, El-Karaksy H. Thrombophilic factors in Egyptian children with portal vein thrombosis. Indian J Gastroenterol 2007;26:252-3.
12. Bhattacharyya M, Makharia G, Kannan M, Ahmed RP, Gupta PK, Saxena R. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 2004;121:844-7.
13. Li XM, Wei YF, Hao HL, et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol 2002;71:11-4.
14. He JA, Hu XH, Fan YY, et al. Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric thrombosis. Eur J Vasc Endovasc Surg 2010;39:508-13.
15. Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood 2008;112:4818-23.
16. Lee YJ, Kang SW, Yang JI, Choi YM, Sheen D, Lee EB, Choi SW, Song YW. Coagulation parameters and plasma total homocysteine levels in Behcet's disease. Thromb Res 2002;106:19-24.
17. Senaratne MP, Griffiths J, Nagendran J. Elevation of plasma homocysteine levels associated with acute myocardial infarction. Clin Invest Med 2000;23:220-6.
18. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996;143:1257-65.
19. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999;96:12810-5.
20. Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Scala I, Andria G, Botto L. Frequency of the mutation 677C-T of methylenetetrahydrofolate reductase gene on a sample of 652 Spanish liveborn infants. Med Clin (Barc) 2004;122:361-4.
21. Vayá A, Gómez I, Mira Y, Ferrando F, Corella D. Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects. Thromb Haemost 2008;99:1132-4.
22. Ricart JM, Vayá A, Todolí J, Calvo J, Villa P, Estellés A, España F, Santaolaria M, Corella D, Aznar J. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 2006;95:618-24.
23. García ClosasR, Serra MajemL, Sabater SalesG, Olmos Castellvell M, Ribas Barba L, Salleras Sanmartí L. Distribution of the serum concentration of vitamin C, folic acid and vitamin B12 in a representative simple of the adult population of Catalonia (Spain). Med Clin (Barc) 2009;118:135-41.
24. Glueck CJ, Shaw P, Lang JE, Tracy T, Sieve-Smith L, Wang Y. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995;75:132-6.
25. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-8.
26. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81:645-72.